A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)
Clinical trial NCT03662334 · COMPLETED
Trial details
- NCT number
- NCT03662334
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-03
- Primary completion
- 2014-02-27
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.